Market Research Report
Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market: Size, Trend, Share, Opportunity Analysis, and Forecast, 2014-2025
|Published by||Progressive Markets Research||Product code||511115|
|Published||Content info||150 Pages
Delivery time: 1-2 business days
|Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market: Size, Trend, Share, Opportunity Analysis, and Forecast, 2014-2025|
|Published: March 1, 2017||Content info: 150 Pages||
Cardiac monitoring is a technique for continuously monitoring the heart rhythm and its activity. Cardiac monitoring helps physicians to discover cardiac arrhythmia, atrial fibrillation, atrial flutter, and other heart disorders and aids in determining heart health and faster diagnosis. Cardiac monitoring and cardiac rhythm management devices are used worldwide to cure and monitor several serious cardiac disorders thereby ensuring that a patient has a well-functioning heart. The global cardiac monitoring and cardiac rhythm management devices market is expected to grow at a CAGR of 6.2% from 2017 to 2025.
On the basis of product type, the market is divided into electrocardiogram (ECG) devices, implantable loop recorders (ILR), cardiac output monitoring (COM) devices, event monitors, pacemakers, cardiac resynchronization therapy (CRT) devices, defibrillators, and ventricular assist devices (VADs). According to end user, the market is divided into hospitals & clinics, home settings, and ambulatory surgical centers (ASCs). Geographic breakdown and deep analysis of each of the aforementioned segments have resulted into the following regions: North America, Europe, Asia-Pacific, and LAMEA.
Market players adopted different strategies, such as product development and product approval to establish their foothold in the market. For instance, in August 2016, Boston Scientific Corp. received an FDA approval for Emblem MRI S-ICD system. The system is MRI labeled; hence, this enables patients implanted with S-ICD system to undergo an MRI scan safely. This has strengthened the company's S-ICD portfolio. The top players in the global cardiac monitoring and cardiac rhythm management devices market include Abiomed Inc, Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corp., Cardiac Science Corporation, General Electric Co. (GE), Hill-Rom Holdings, Inc., St. Jude Medical, Inc., Medtronic PLC, and Nihon Kohden Corp.
By Product Type
5.2.1 Historical market size by region, 2014-2016
5.2.2 Market forecast by region, 2017-2025